Androgenetic Alopecia (AGA)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Androgenetic Alopecia (AGA) trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 21 trials

RecruitingPhase 1/2

NCT07317544

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

The goal of this clinical trial is to learn if ABS-201 (a new medication) is safe and tolerable when used to improve hair growth in men and women. The trial wil…

Australia227 participantsStarted 2025-12-03

Treatment: ABS-201 IV Single Dose, Placebo IV

RecruitingNot Applicable

NCT07563036

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Androgenetic alopecia is a common form of progressive hair loss. This prospective single-arm pre-post interventional study aims to assess tissue Janus Kinase 2…

Egypt25 participantsStarted 2026-02-01

Treatment: Topical Minoxidil 5% Solution, Scalp Punch Biopsy

RecruitingPhase 2

NCT07335367

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

Research Purpose The objective of this study is to determine the safety and efficacy of combined PRP and BTX-A injection therapy for Androgenetic Alopecia (AGA…

China76 participantsStarted 2026-01-09

Treatment: Injection of PRP combined with Botulinum Toxin Type A into the alopecic area(s), PRP-only injection into the alopecic area

RecruitingNot Applicable

NCT07502976

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Androgenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety o…

Egypt60 participantsStarted 2026-01-01

Treatment: Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution

RecruitingPhase 2

NCT07370519

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

This is a single-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate whether topical application of Lactobacillus reuteri c…

China388 participantsStarted 2026-01-25

Treatment: Lactobacillus reuteri, Inactivated Lactobacillus reuteri

RecruitingPhase 3

NCT07435012

Androgenic Alopecia TH07 Clinical Trial

The goal of this clinical trial is to learn whether a new topical solution, TH07, can help treat androgenic alopecia in men and to learn more about its safety.…

Canada420 participantsStarted 2026-04

Treatment: TH07, TH07

All recent trials (100 shown)

CompletedNot Applicable

NCT07551271

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

A study on the therapeutic effect of platelet-rich plasma in the treatment of androgenetic alopecia

China30 participantsStarted 2025-01-01

Treatment: PRP

Not Yet RecruitingNot Applicable

NCT07536100

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

This study aims to evaluate the effectiveness and tolerability of a peptide-based hair serum compared with topical minoxidil in patients with androgenetic alope…

Thailand80 participantsStarted 2026-04-16

Treatment: Veneze peptide hair serum, Topical minoxidil

Androgenetic Alopecia (AGA)

Trial phase breakdown

Trial status

Actively recruiting — 21 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Androgenic Alopecia TH07 Clinical Trial

All recent trials (100 shown)

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

Trial phase breakdown

Trial status

Actively recruiting — 21 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Androgenic Alopecia TH07 Clinical Trial

All recent trials (100 shown)

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

The Effect of Nanofat Injection on Androgenetic Alopecia

Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Diagnostics of Clinical Hyperandrogenism

Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

XVIE to Treat Androgenetic Alopecia (AGA)

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.

Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study

Safety and Efficacy of VDPHL01 in Males With AGA

Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss

Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINOR…

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Do…